Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cognitive Dysfunction in Patients with Breast Cancer Undergoing Systemic Therapy

NCT06662474 is registered in ClinicalTrials.gov with Grigore T. Popa University of Medicine and Pharmacy as lead sponsor.

NCT NCT06662474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cognitive Dysfunction in Patients with Breast Cancer Undergoing Systemic Therapy
Lead sponsor
Grigore T. Popa University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemobrain, cognitive impairment